Synthesis and structural elucidation of 1-(3-C-ethynyl-4-thio-β-D-ribofuranosyl)cytosine (4′-thioECyd)

A practical synthesis of 1,4-anhydro-4-thio-D-ribitol (5) via 1,4-dibromo-1,4-dideoxy-2,3,5-tri-O-benzyl-L-lyxitol (12) is described. This method reduced our previous eleven step procedure starting from D-ribose by three steps. The Pummerer reaction of 1,4-anhydro-2-O-(2,4-dimethoxybenzoyl)-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-4-sulfinyl-D-ribitol (6) in the presence of N4-benzoylcytosine afforded the 4′-thiocytidine derivative 7b on a large scale. Starting with the resulting 7b, 1-(3-C-ethynyl-4-thio-β-D-ribofuranosyl)cytosine (4; 4′-thioECyd), of which the 4′-oxo congener ECyd (3) is a new type of potent antineoplastic nucleoside developed in our group, was synthesized via elaborate protection and deprotection procedures, and successive reaction with cerium trimethylsilylacetylide. X-Ray crystal structures of 4′-thioECyd (4) and ECyd (3) are presented in this paper. Although striking differences in bond lengths and angles were observed in C1′–S4′ and C4′–S4′, and C4′–S4′–C1′, the overall structures of each compound, including the sugar puckering mode and the syn/anti conformation around the glycosyl bond, were similar.

[1]  M. Fukushima,et al.  Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106 , 2002, Japanese journal of cancer research : Gann.

[2]  N. Minakawa,et al.  The Stereoselective Synthesis of 4‘-β-Thioribonucleosides via the Pummerer Reaction† , 2000 .

[3]  J. Montgomery,et al.  Synthesis of 4′-Thio-β-D-arabinofuranosylcytosine (4′-Thio-ara-C) and Comparison of Its Anticancer Activity with That of Ara-C , 2000, Nucleosides, nucleotides & nucleic acids.

[4]  M. Yokoyama.  Synthesis and Biological Activity of Thionucleosides , 2000 .

[5]  N. Minakawa,et al.  Nucleosides and nucleotides. 189. Investigation of the stereoselective coupling of thymine with meso-thiolane-3,4-diol-1-oxide derivatives via the Pummerer reaction , 1999 .

[6]  O. Yamazaki,et al.  Synthetic utility of 1,1,2,2-tetraaryldisilanes: radical reduction of alkyl phenyl chalcogenides , 1999 .

[7]  M. Fukushima,et al.  Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)uracil , 1999, Cancer Chemotherapy and Pharmacology.

[8]  J. M. Riordan,et al.  Synthesis and biological activity of certain 4'-thio-D-arabinofuranosylpurine nucleosides. , 1998, Journal of medicinal chemistry.

[9]  M. Fukushima,et al.  Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1. , 1998, Journal of medicinal chemistry.

[10]  A. Burger,et al.  Diastereofacial Selective Addition of Ethynylcerium Reagent and Barton-McCombie Reaction as the Key Steps for the Synthesis of C-3'-Ethynylribonucleosides and of C-3'-Ethynyl-2'-deoxyribonucleosides. , 1997, The Journal of organic chemistry.

[11]  Y. Endo,et al.  Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells. , 1997, Cancer letters.

[12]  M. Fukushima,et al.  Nucleosides and Nucleotides. 158. 1-(3-C-Ethynyl-β-d-ribo-pentofuranosyl)- cytosine, 1-(3-C-Ethynyl-β-d-ribo-pentofuranosyl)uracil, and Their Nucleobase Analogues as New Potential Multifunctional Antitumor Nucleosides with a Broad Spectrum of Activity1 , 1996 .

[13]  A. Matsuda,et al.  Cell kill kinetics of an antineoplastic nucleoside, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytosine. , 1996, Biochemical pharmacology.

[14]  A. Matsuda,et al.  A Novel Synthesis of New Antineoplastic 2‘-Deoxy-2‘-substituted-4‘-thiocytidines , 1996 .

[15]  A. Burger,et al.  Rapid and efficient stereocontrolled synthesis of C-3′-ethynyl ribo and xylonucleosides by organocerium additions to 3′-ketonucleosides , 1995 .

[16]  H. Pelicano,et al.  A new synthesis of some 4'-thio-D-ribonucleosides and preliminary enzymatic evaluation , 1994 .

[17]  J. Uenishi,et al.  Synthesis and X-Ray Structure of 4′-Thiothymidine , 1993 .

[18]  R. T. Walker,et al.  Conformation of two 4'-thio-2'-deoxynucleoside analogs studied by 5000-MHz proton NMR spectroscopy and x-ray crystallography. , 1992 .

[19]  R. T. Walker,et al.  The synthesis and antiviral activity of some 4'-thio-2'-deoxy nucleoside analogues. , 1991, Journal of medicinal chemistry.

[20]  A. Matsuda,et al.  Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative. , 1991, Cancer research.

[21]  A. Matsuda,et al.  Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives. , 1991, Journal of medicinal chemistry.

[22]  K. Nagasawa,et al.  Organosulfur Chemistry. II. Use of Dimethyl Sulfoxide ; a Facile Synthesis of Cyclic Sulfides , 1985 .

[23]  G. Hakimelahi,et al.  Nitrate ion as catalyst for selective silylations of nucleosides , 1982 .

[24]  R. Whistler,et al.  Synthesis and biological activity of 5-fluoro-4'-thiouridine and some related nucleosides. , 1975, Journal of medicinal chemistry.

[25]  S. Danyluk,et al.  Nuclear magnetic resonance studies of 5'-ribo- and deoxyribonucleotide structures in solution. , 1974, Biochemistry.

[26]  A. Bose,et al.  A facile replacement of hydroxyl by halogen with inversion , 1974 .

[27]  M. Sundaralingam,et al.  Conformational analysis of the sugar ring in nucleosides and nucleotides. Improved method for the interpretation of proton magnetic resonance coupling constants. , 1973, Journal of the American Chemical Society.